Halper Sadeh LLC is investigating whether certain UnitedHealth Group officers and directors violated their fiduciary duties to shareholders. Long-term shareholders of UnitedHealth stock may be eligible to seek corporate governance reforms, financial incentives, or other relief. The firm offers free consultations and works on a contingency fee basis, encouraging shareholders to act quickly due to potential time limits. This investigation aims to improve company oversight and protect shareholder value.
UnitedHealth Group's stock is currently priced at USD 369.57 on Pluang, showing a 1.70% decrease in the last day. The stock has a dividend yield of 2.47% and a market cap of $337.48 billion. These figures are as of Oct 09, 2026 02:02 WIB.
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...
UnitedHealth Group's stock has risen from $300 to around $440-$450, reflecting a recovery in margins and key business areas like Medicare Advantage and Optum Health. However, the current valuation leaves little room for safety, as the market already ...
UnitedHealth Group (UNH) is rated a Buy as its fundamentals improve and its price-to-earnings ratio hits a decade low at 19.95, despite being cheaper than peers. Key focus areas for Q3 include commercial cost trends, star ratings, cash flow guidance,...
